In a recent work, the authors characterized the expression of Siglec5, 7, 9 on MDSC both from peripheral blood and glioma infiltrating cells and found the respective ligands both on GB cell lines and patient-derived glioma tissue samples (Table 1). The gene discussed is SIGLEC5; the disease is central nervous system cancer.